1. Home
  2. FOSL vs NVCT Comparison

FOSL vs NVCT Comparison

Compare FOSL & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fossil Group Inc.

FOSL

Fossil Group Inc.

HOLD

Current Price

$4.02

Market Cap

265.3M

ML Signal

HOLD

Logo Nuvectis Pharma Inc.

NVCT

Nuvectis Pharma Inc.

HOLD

Current Price

$10.16

Market Cap

274.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOSL
NVCT
Founded
1984
2020
Country
United States
United States
Employees
4500
N/A
Industry
Consumer Specialties
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
265.3M
274.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
FOSL
NVCT
Price
$4.02
$10.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$7.00
$10.00
AVG Volume (30 Days)
848.6K
104.6K
Earning Date
05-13-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.27
$5.55
52 Week High
$5.75
$13.34

Technical Indicators

Market Signals
Indicator
FOSL
NVCT
Relative Strength Index (RSI) 41.42 51.46
Support Level $3.71 $7.79
Resistance Level $4.23 $13.34
Average True Range (ATR) 0.34 1.00
MACD -0.01 -0.12
Stochastic Oscillator 33.86 19.23

Price Performance

Historical Comparison
FOSL
NVCT

About FOSL Fossil Group Inc.

Fossil Group Inc is a design, innovation, and distribution company in consumer fashion accessories, offering products such as watches, jewelry, handbags, small leather goods, belts, and sunglasses. It designs, develops, markets, and distributes products under its owned brands FOSSIL, SKAGEN, MICHELE, RELIC, and ZODIAC. It operates through Americas, Europe, and Asia segments, each including sales to wholesale and distributor customers, as well as Company-owned retail stores and e-commerce activities based on the location of the selling entity. The Americas segment contributes the majority of revenue and includes sales across Canada, Latin America, and the United States, while the Europe and Asia segments cover their respective regions. Each segment provides similar products and services.

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Share on Social Networks: